Compare INSG & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INSG | QSI |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.1M | 161.8M |
| IPO Year | 2000 | N/A |
| Metric | INSG | QSI |
|---|---|---|
| Price | $12.09 | $0.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $15.33 | $1.00 |
| AVG Volume (30 Days) | 121.0K | ★ 3.1M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $313,832,000.00 | N/A |
| Revenue This Year | $16.21 | N/A |
| Revenue Next Year | $13.28 | $618.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.24 | $0.72 |
| 52 Week High | $18.08 | $3.10 |
| Indicator | INSG | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 54.49 | 34.20 |
| Support Level | $10.79 | N/A |
| Resistance Level | $12.95 | $1.11 |
| Average True Range (ATR) | 0.72 | 0.05 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 57.37 | 12.24 |
Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.